1887

Abstract

SDZ NIM 811 is a cyclosporin A (CsA) analogue that is completely devoid of immunosuppressive capacity but exhibits potent and selective antihuman immunodeficiency virus type 1 (HIV-1) activity. Binding to cyclophilin A, the intracellular receptor for cyclosporins, is a prerequisite for HIV-1 inhibition by cyclosporins. Cyclophilin A was demonstrated to bind to HIV-1 p24 and this cyclophilin-Gag interaction leads to the incorporation of cyclophilin Ainto HIV-1 virions. SDZ NIM 811 inhibitsthis protein interaction, and this is likely to be the molecular basis for its antiviral activity. Here, we show that in activated primary T cells SDZ NIM 811 interferes with two stages of the virus replication cycle: (i) translocation of pre-integration complexes into the nucleus and (ii) production of infectious virus particles. SDZ NIM 811 not only inhibits translocation of HIV-1 pre-integration complexes in primary T cells, but also in a growth-arrested T cell line. , most T lymphocytes are quiescent, but serve nevertheless as a major and inducible HIV-1 reservoir in infected individuals. Significant amounts of cyclophilin A were found to be associated with virus particles propagated in primary T cells. SDZ NIM 811 caused a strong reduction in the amount of incorporated cyclophilin A, thereby reducing infectivity. Thus, cyclophilin A seems to be necessary for HIV-1 replication in primary T cells.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-4-825
1997-04-01
2024-10-06
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/4/9129655.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-4-825&mimeType=html&fmt=ahah

References

  1. Aberham C., Weber S., Phares W. 1996; Spontaneous mutations in the human immunodeficiency virus type 1 gene that affect viral replication in the presence of cyclosporins. Journal of Virology 70:3536–3544
    [Google Scholar]
  2. Bartz S., Hohenwalter E., Hu M., Rich D. H., Malkovsky M. 1995; Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A. Proceedings of the National Academy of Sciences USA: 925381–5385
    [Google Scholar]
  3. Billich A., Hammerschmid F., Peichl P., Wegner R., Zenke G.Quesniaux, Rosenwirth B. 1995; Mode of action of SDZ NIM 811, a non immuno-suppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with HIV protein-cyclophilin interaction. Journal of Virology 69:2451–2461
    [Google Scholar]
  4. Brown P. O., Bowerman B., Varmus H. E., Bishop J. M. 1987; Correct integration of retroviral DNA in vitro. Cell 49:347–356
    [Google Scholar]
  5. Bukrinsky M. I., Sharova N., Dempsey M. P., Stanwick T. L., Bukrinskaya A. G., Haggerty S., Stevenson M. 1992; Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proceedings of the National Academy of Sciences USA: 896580–6584
    [Google Scholar]
  6. Bukrinsky M. I., Haggerty S., Dempsey M. P., Sharova N., Adzhubei A., Spitz L., Goldfarb D., Emerman M., Stevenson M. 1993; A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666–669
    [Google Scholar]
  7. Chirgwin J. M., Przybyla A. E., McDonald R. J., Rutter W. J. 1979; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
    [Google Scholar]
  8. De Clercq E., Yamamoto N., Pauwels R., Balzarini J., Witvrouw M., De Vreese K., Debyser Z., Rosenwirth R., Peichl P., Datema R., Thornton D., Kerlj R., Gaul F., Padmanabhan S., Bridger G., Henson G., Abrams M. 1994; Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrobial Agents and Chemotherapy 38:668–674
    [Google Scholar]
  9. Ercolani L., Florence B., Denaro M., Alexander M. 1988; Isolation and complete sequence of a functional human glyceraldehyde-3- phosphate dehydrogenase. Journal of Biological Chemistry 263:15335–15341
    [Google Scholar]
  10. Fischer G., Wittmann-Liebold B., Lang K., Kiefhaber T., Schmid F. X. 1989; Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337:476–478
    [Google Scholar]
  11. Franke E. K., Yuan H. E. H., Luban J. 1994; Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359–362
    [Google Scholar]
  12. Gowda S. D., Stein B. S., Mohagheghpour N., Benike C. J., Engleman E. G. 1989; Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. Journal of Immunology 142:773–780
    [Google Scholar]
  13. Handschumacher R. E., Warding M. W., Rice J., Drugge R. J., Speicher D. W. 1984; Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226:544–547
    [Google Scholar]
  14. Hirt B. 1967; Selective extraction of polyoma DNA from infected mouse cell culture. Journal of Molecular Biology 26:365–369
    [Google Scholar]
  15. Kim S., Byrn R., Groopman J., Baltimore D. 1989; Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. Journal of Virology 63:3708–3713
    [Google Scholar]
  16. Koettnitz K., Wöhl T., Kappel B., Lottspeich F., Hauber J., Bevec D. 1995; Identification of a new member of the human eIF-5A gene family. Gene 159:283–284
    [Google Scholar]
  17. Li G., Simm M., Potash M. J., Volsky D. J. 1993; Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells. Journal of Virology 67:3969–3977
    [Google Scholar]
  18. Luban J., Bossolt K. L., Franke E. K., Kalpana G. V., Goff S. P. 1993; Human immunodeficiency virus type 1 gag protein binds to cyclophilin A and B. Cell 73:1067–1078
    [Google Scholar]
  19. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  20. Miyoshi I., IKunonishi I., Yoshimoto S., Akagi T., Ohtsuki Y., Shiraishi Y., Nagata K., Hinuma Y. 1981; Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294:770–771
    [Google Scholar]
  21. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. 1984; Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500
    [Google Scholar]
  22. Ratner L., Haseltine W., Patarca R., Livak K. J., Stacich B., Josephs S. F., Doran E. R., Rafalski J. A., Whitehorn E. A., Baumeister K., Ivanoff L., Petteway S. R., Pearson M. L., Lautenberger J. A., Papas T. S., Ghryeb J., Chang N. T., Gallo R. C., Wong-Staal F. 1985; Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313:277–284
    [Google Scholar]
  23. Rosenwirth B., Billich A., Datema R., Donatch P., Hammerschmid F., Harrison R., Hiestand P., Jaksche H., Mayer P., Peichl P., Quesniaux V., Schatz F., Schuurman J., Traber R., Wenger R., Wolff B., Zenke G., Zurini M. 1994; Inhibition of HIV-1 replication by SDZ NIM 811, a non-immunosuppressive cyclosporin A analog. Antimicrobial Agents and Chemotherapy 38:1763–1772
    [Google Scholar]
  24. Schreiber S. L., Crabtree G. R. 1992; The mechanism of action of cyclosporin A and FK506. Immunology Today 13:136–142
    [Google Scholar]
  25. Schuitemaker H., Koostra N. A., Fouchier R. A. M., Hooibrink B., Miedema F. 1994; Productive HIV-1 infection of macrophages restricted to cell fraction with proliferative capacity. EMBO Journal 13:5929–5936
    [Google Scholar]
  26. Shieh B. H., Stamnes M. A., Seavella S., Harris G. L., Zuker C. S. 1989; The ninaA gene required for visual transduction in Drosophila encodes a homologue of cyclosporin A-binding protein. Nature 338:67–70
    [Google Scholar]
  27. Steinkasserer A., Harrison R., Billich A., Hammerschmid F., Werner G., Wolff B., Peichl P.Plafi, Schnitzel W., Mlynar E., Rosenwirth B. 1995; Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication. Journal of Virology 69: 814–824
    [Google Scholar]
  28. Stevenson M., Stanwick T. L., Dempsey M. P., Lamonica C. A. 1990; HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO Journal 9: 1551–1560
    [Google Scholar]
  29. Takahashi N., Hayano T., Suzuki M. 1989; Peptidyl-prolyl-cis- trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337:473–475
    [Google Scholar]
  30. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C. T., Sodroski J., Göttlinger H. G. 1994; Functional association of cyclophilin A with HIV-1 virions. Nature 372:363–365
    [Google Scholar]
  31. Traber R., Kobel H., Loosli H. R., Senn H., Rosenwirth B., Lawen A. 1994; [MeIle4] cyclosporin, a novel natural cyclosporin with anti- HIV activity : structural elucidation, biosynthesis and biological properties. Antiviral Chemistry and Chemotherapy 5:331–339
    [Google Scholar]
  32. Walsh C. T., Zydowsky L. D., McKeon F. D. 1992; Cyclosporin A, the cyclophilin class of peptidyl-prolyl isomerases, and blockade of T cell signal transduction. Journal of Biological Chemistry 19:13115–13118
    [Google Scholar]
  33. Willenbrink W., Halaschek J., Schuffenhauer S., Kunz J., Steinkasserer A. 1995; Cyclophilin A, the major intracellular receptor for the immunosuppressant cyclosporin A, maps to chromosome 7p11.2- p13 : four pseudogenes map to chromosomes 3, 10, 14 and 18. Genomics 28:101–104
    [Google Scholar]
  34. Willis J. W., Craven R. C. 1991; Form, function, and use of retroviral gag proteins. AIDS 5:639–654
    [Google Scholar]
  35. Zack J. A., Arrigo J., Weitsman S. R., Go A. S., Haislip A., Chen I. S. Y. 1990; HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213–222
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-78-4-825
Loading
/content/journal/jgv/10.1099/0022-1317-78-4-825
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error